Sanofi Adr Stock Total Asset

SNY Stock

USD 49.50 0.71 1.41%

Sanofi ADR fundamentals help investors to digest information that contributes to Sanofi ADR's financial success or failures. It also enables traders to predict the movement of Sanofi Stock. The fundamental analysis module provides a way to measure Sanofi ADR's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sanofi ADR stock.

	Last Reported	Projected for Next Year
Total Assets	126.5 B	88.2 B
Intangibles To Total Assets	0.58	0.38

Total Assets is likely to drop to about 88.2 B in 2024. Intangibles To Total Assets is likely to drop to 0.38 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Sanofi ADR Company Total Asset Analysis

Sanofi ADR's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Total Asset

Tangible Assets

+

Intangible Assets

More About Total Asset | All Equity Analysis

Current Sanofi ADR Total Asset

126.46 B

Most of Sanofi ADR's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sanofi ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Sanofi Total Asset Driver Correlations

Understanding the fundamental principles of building solid financial models for Sanofi ADR is extremely important. It helps to project a fair market value of Sanofi Stock properly, considering its historical fundamentals such as Total Asset. Since Sanofi ADR's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sanofi ADR's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sanofi ADR's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Accounts Payable	Net Receivables	Good Will	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue	Retained Earnings	Long Term Debt	Property Plant Equipment	Treasury Stock	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.66	0.78	0.23	1.0	-0.61	0.98	0.9	0.59	0.27	0.84	0.17	0.01	0.68	0.56	0.01	0.47	0.32	-0.52	-0.03	0.57	0.54	0.42	-0.19	-0.02
Total Stockholder Equity	0.99		0.57	0.74	0.21	0.99	-0.62	0.95	0.89	0.57	0.3	0.84	0.12	0.03	0.63	0.59	-0.02	0.49	0.32	-0.5	0.08	0.52	0.49	0.42	-0.18	-0.01
Net Debt	0.66	0.57		0.58	0.25	0.66	-0.32	0.77	0.47	0.52	0.19	0.48	0.26	-0.26	0.64	0.25	0.25	0.35	0.16	-0.33	-0.65	0.61	0.54	0.38	-0.41	-0.05
Accounts Payable	0.78	0.74	0.58		-0.15	0.8	-0.33	0.8	0.83	0.54	-0.2	0.59	0.17	0.13	0.61	0.28	-0.11	0.33	0.71	-0.56	-0.09	0.53	0.52	0.31	0.11	-0.12
Net Receivables	0.23	0.21	0.25	-0.15		0.22	-0.78	0.26	0.06	0.02	0.22	0.46	0.75	0.21	0.32	0.39	-0.13	-0.48	-0.56	-0.03	-0.23	-0.18	-0.13	-0.37	-0.37	-0.11
Good Will	1.0	0.99	0.66	0.8	0.22		-0.61	0.98	0.9	0.58	0.25	0.83	0.17	0.03	0.7	0.57	-0.03	0.48	0.35	-0.55	-0.04	0.56	0.54	0.43	-0.2	-0.03
Short Term Investments	-0.61	-0.62	-0.32	-0.33	-0.78	-0.61		-0.6	-0.47	-0.29	-0.25	-0.87	-0.71	-0.27	-0.58	-0.65	0.16	0.28	0.17	0.23	0.03	0.07	0.01	0.18	0.16	-0.02
Total Liab	0.98	0.95	0.77	0.8	0.26	0.98	-0.6		0.89	0.6	0.23	0.81	0.23	-0.02	0.72	0.51	0.04	0.44	0.31	-0.54	-0.16	0.62	0.6	0.41	-0.2	-0.04
Total Current Assets	0.9	0.89	0.47	0.83	0.06	0.9	-0.47	0.89		0.5	0.05	0.69	0.08	0.14	0.54	0.35	-0.01	0.43	0.44	-0.64	0.16	0.66	0.68	0.39	0.02	-0.05
Short Term Debt	0.59	0.57	0.52	0.54	0.02	0.58	-0.29	0.6	0.5		0.1	0.55	0.07	-0.16	0.25	0.27	0.35	0.23	0.25	0.1	-0.09	0.35	0.33	0.35	-0.09	0.07
Intangible Assets	0.27	0.3	0.19	-0.2	0.22	0.25	-0.25	0.23	0.05	0.1		0.34	-0.28	-0.24	0.01	0.22	0.16	0.34	-0.54	-0.07	0.0	0.19	0.17	0.52	-0.53	0.64
Common Stock	0.84	0.84	0.48	0.59	0.46	0.83	-0.87	0.81	0.69	0.55	0.34		0.44	0.08	0.69	0.74	-0.01	0.08	0.08	-0.29	0.03	0.16	0.18	0.12	-0.07	0.13
Current Deferred Revenue	0.17	0.12	0.26	0.17	0.75	0.17	-0.71	0.23	0.08	0.07	-0.28	0.44		0.36	0.41	0.32	-0.23	-0.71	-0.11	0.08	-0.24	-0.36	-0.29	-0.69	0.11	-0.44
Retained Earnings	0.01	0.03	-0.26	0.13	0.21	0.03	-0.27	-0.02	0.14	-0.16	-0.24	0.08	0.36		-0.15	-0.17	-0.68	-0.33	0.1	-0.24	0.3	-0.2	-0.07	-0.35	0.17	-0.16
Long Term Debt	0.68	0.63	0.64	0.61	0.32	0.7	-0.58	0.72	0.54	0.25	0.01	0.69	0.41	-0.15		0.77	0.07	0.16	0.36	-0.5	-0.34	0.24	0.2	0.09	-0.02	-0.13
Property Plant Equipment	0.56	0.59	0.25	0.28	0.39	0.57	-0.65	0.51	0.35	0.27	0.22	0.74	0.32	-0.17	0.77		0.13	0.06	0.16	-0.14	0.1	-0.13	-0.16	-0.04	-0.01	-0.06
Treasury Stock	0.01	-0.02	0.25	-0.11	-0.13	-0.03	0.16	0.04	-0.01	0.35	0.16	-0.01	-0.23	-0.68	0.07	0.13		0.26	0.0	0.24	0.0	0.31	0.32	0.24	-0.12	0.11
Deferred Long Term Liab	0.47	0.49	0.35	0.33	-0.48	0.48	0.28	0.44	0.43	0.23	0.34	0.08	-0.71	-0.33	0.16	0.06	0.26		0.34	-0.42	0.02	0.73	0.63	0.84	-0.3	0.23
Long Term Investments	0.32	0.32	0.16	0.71	-0.56	0.35	0.17	0.31	0.44	0.25	-0.54	0.08	-0.11	0.1	0.36	0.16	0.0	0.34		-0.31	0.16	0.25	0.24	0.12	0.4	-0.37
Short Long Term Debt	-0.52	-0.5	-0.33	-0.56	-0.03	-0.55	0.23	-0.54	-0.64	0.1	-0.07	-0.29	0.08	-0.24	-0.5	-0.14	0.24	-0.42	-0.31		0.11	-0.64	-0.66	-0.47	0.25	-0.22
Net Tangible Assets	-0.03	0.08	-0.65	-0.09	-0.23	-0.04	0.03	-0.16	0.16	-0.09	0.0	0.03	-0.24	0.3	-0.34	0.1	0.0	0.02	0.16	0.11		-0.21	-0.1	-0.16	0.4	-0.09
Long Term Debt Total	0.57	0.52	0.61	0.53	-0.18	0.56	0.07	0.62	0.66	0.35	0.19	0.16	-0.36	-0.2	0.24	-0.13	0.31	0.73	0.25	-0.64	-0.21		0.98	0.76	-0.39	0.18
Capital Surpluse	0.54	0.49	0.54	0.52	-0.13	0.54	0.01	0.6	0.68	0.33	0.17	0.18	-0.29	-0.07	0.2	-0.16	0.32	0.63	0.24	-0.66	-0.1	0.98		0.68	-0.35	0.2
Net Invested Capital	0.42	0.42	0.38	0.31	-0.37	0.43	0.18	0.41	0.39	0.35	0.52	0.12	-0.69	-0.35	0.09	-0.04	0.24	0.84	0.12	-0.47	-0.16	0.76	0.68		-0.5	0.61
Net Working Capital	-0.19	-0.18	-0.41	0.11	-0.37	-0.2	0.16	-0.2	0.02	-0.09	-0.53	-0.07	0.11	0.17	-0.02	-0.01	-0.12	-0.3	0.4	0.25	0.4	-0.39	-0.35	-0.5		-0.38
Capital Stock	-0.02	-0.01	-0.05	-0.12	-0.11	-0.03	-0.02	-0.04	-0.05	0.07	0.64	0.13	-0.44	-0.16	-0.13	-0.06	0.11	0.23	-0.37	-0.22	-0.09	0.18	0.2	0.61	-0.38

Click cells to compare fundamentals

Sanofi Total Asset Historical Pattern

Today, most investors in Sanofi ADR Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sanofi ADR's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Sanofi ADR total asset as a starting point in their analysis.

Sanofi ADR Total Asset

Timeline

Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.

Competition

Predict Sanofi ADR

Total Assets Over Time

Sanofi Total Assets

Total Assets

88.22 Billion

At this time, Sanofi ADR's Total Assets are fairly stable compared to the past year.

Based on the latest financial disclosure, Sanofi ADR has a Total Asset of 126.46 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The total asset for all United States stocks is significantly lower than that of the firm.

Sanofi Total Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sanofi ADR's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sanofi ADR could also be used in its relative valuation, which is a method of valuing Sanofi ADR by comparing valuation metrics of similar companies.

Sanofi ADR is currently under evaluation in total asset category among related companies.

Sanofi ADR Current Valuation Drivers

We derive many important indicators used in calculating different scores of Sanofi ADR from analyzing Sanofi ADR's financial statements. These drivers represent accounts that assess Sanofi ADR's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Sanofi ADR's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	112.0B	98.7B	110.9B	112.5B	101.2B	67.8B
Enterprise Value	128.5B	108.4B	123.3B	120.9B	108.9B	73.8B

Sanofi ADR ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Sanofi ADR's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Sanofi ADR's managers, analysts, and investors.

Environmental

Governance

Social

Sanofi ADR Institutional Holders

Institutional Holdings refers to the ownership stake in Sanofi ADR that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Sanofi ADR's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Sanofi ADR's value.

		Shares
Mondrian Investment Partners Ltd	2023-12-31	2.8 M
Envestnet Asset Management Inc	2023-12-31	2.6 M
Natixis Advisors, Llc.	2023-12-31	2.5 M
Hotchkis & Wiley Capital Management Llc	2023-12-31	2.3 M
Wells Fargo & Co	2023-12-31	2.3 M
Pictet Asset Manangement Sa	2023-12-31	2.1 M
Royal Bank Of Canada	2023-12-31	2 M
Equity Investment Corp	2023-12-31	1.9 M
Raymond James & Associates	2023-12-31	1.8 M
Dodge & Cox	2023-12-31	78.3 M
Fmr Inc	2023-12-31	20.4 M

Sanofi Fundamentals

	Return On Equity	0.0727
	Return On Asset	0.0454
	Profit Margin	0.1 %
	Operating Margin	0.18 %
	Current Valuation	71.55 B
	Shares Outstanding	2.5 B
	Shares Owned By Institutions	10.21 %
	Number Of Shares Shorted	5.44 M
	Price To Earning	7.78 X
	Price To Book	1.44 X
	Price To Sales	2.52 X
	Revenue	43.07 B
	Gross Profit	31.7 B
	EBITDA	12.96 B
	Net Income	5.4 B
	Cash And Equivalents	6.9 B
	Cash Per Share	2.76 X
	Total Debt	18.42 B
	Debt To Equity	0.30 %
	Current Ratio	1.30 X
	Book Value Per Share	59.17 X
	Cash Flow From Operations	10.26 B
	Short Ratio	2.18 X
	Earnings Per Share	1.94 X
	Price To Earnings To Growth	0.84 X
	Target Price	58.92
	Number Of Employees	86.09 K
	Beta	0.45
	Market Capitalization	125.13 B
	Total Asset	126.46 B
	Retained Earnings	67.5 B
	Working Capital	6.46 B
	Current Asset	24.93 B
	Current Liabilities	16.82 B
	Annual Yield	0.04 %
	Five Year Return	3.85 %
	Net Asset	126.46 B

About Sanofi ADR Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Sanofi ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sanofi ADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sanofi ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Sanofi ADR Investors Sentiment

The influence of Sanofi ADR's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Sanofi. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Sanofi ADR's public news can be used to forecast risks associated with an investment in Sanofi. The trend in average sentiment can be used to explain how an investor holding Sanofi can time the market purely based on public headlines and social activities around Sanofi ADR. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Sanofi ADR's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Sanofi ADR's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Sanofi ADR's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Sanofi ADR.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sanofi ADR in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sanofi ADR's short interest history, or implied volatility extrapolated from Sanofi ADR options trading.

Currently Active Assets on Macroaxis

MSFT	Microsoft
V	Visa Class A
DD	Dupont De Nemours
CRM	Salesforce
GM	General Motors

When determining whether Sanofi ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sanofi ADR's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sanofi Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sanofi Adr Stock:

How To Invest In Sanofi

Details

Is Sanofi Stock a good investment?

Details

What is Sanofi ADR's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Sanofi ADR Piotroski F Score and Sanofi ADR Altman Z Score analysis.

For more information on how to buy Sanofi Stock please use our How to Invest in Sanofi ADR guide.

You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Sanofi Stock analysis

When running Sanofi ADR's price analysis, check to measure Sanofi ADR's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanofi ADR is operating at the current time. Most of Sanofi ADR's value examination focuses on studying past and present price action to predict the probability of Sanofi ADR's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanofi ADR's price. Additionally, you may evaluate how the addition of Sanofi ADR to your portfolios can decrease your overall portfolio volatility.

	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Transaction History View history of all your transactions and understand their impact on performance
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Technical Analysis Check basic technical indicators and analysis based on most latest market data

Is Sanofi ADR's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sanofi ADR. If investors know Sanofi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sanofi ADR listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.43)

Earnings Share

1.94

Revenue Per Share

18.492

Quarterly Revenue Growth

0.023

Return On Assets

0.0454

The market value of Sanofi ADR is measured differently than its book value, which is the value of Sanofi that is recorded on the company's balance sheet. Investors also form their own opinion of Sanofi ADR's value that differs from its market value or its book value, called intrinsic value, which is Sanofi ADR's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sanofi ADR's market value can be influenced by many factors that don't directly affect Sanofi ADR's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Sanofi ADR's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sanofi ADR is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sanofi ADR's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sanofi Adr Stock Total Asset

Sanofi ADR Company Total Asset Analysis

Total Asset

Tangible Assets

+

Intangible Assets

Current Sanofi ADR Total Asset

Sanofi Total Asset Driver Correlations

Sanofi Total Asset Historical Pattern

Sanofi Total Assets

Total Assets

88.22 Billion

Sanofi Total Asset Peer Comparison

Sanofi ADR Current Valuation Drivers

Sanofi ADR ESG Sustainability

Sanofi ADR Institutional Holders

Sanofi Fundamentals

About Sanofi ADR Fundamental Analysis

Sanofi ADR Investors Sentiment

Currently Active Assets on Macroaxis

Complementary Tools for Sanofi Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY